These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 11481159)
1. Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Musselman DL; Miller AH; Porter MR; Manatunga A; Gao F; Penna S; Pearce BD; Landry J; Glover S; McDaniel JS; Nemeroff CB Am J Psychiatry; 2001 Aug; 158(8):1252-7. PubMed ID: 11481159 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 levels and HPA axis activation in breast cancer patients with major depressive disorder. Soygur H; Palaoglu O; Akarsu ES; Cankurtaran ES; Ozalp E; Turhan L; Ayhan IH Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1242-7. PubMed ID: 17587477 [TBL] [Abstract][Full Text] [Related]
3. Dexamethasone suppression in dementia, depression, and normal aging. Georgotas A; McCue RE; Kim OM; Hapworth WE; Reisberg B; Stoll PM; Sinaiko E; Fanelli C; Stokes PE Am J Psychiatry; 1986 Apr; 143(4):452-6. PubMed ID: 3953888 [TBL] [Abstract][Full Text] [Related]
4. Increased plasma serine concentrations in depression. Maes M; De Backer G; Suy E; Minner B Neuropsychobiology; 1995; 31(1):10-5. PubMed ID: 7708176 [TBL] [Abstract][Full Text] [Related]
5. Serum concentrations of CRP, IL-6, TNF-α and cortisol in major depressive disorder with melancholic or atypical features. Karlović D; Serretti A; Vrkić N; Martinac M; Marčinko D Psychiatry Res; 2012 Jun; 198(1):74-80. PubMed ID: 22386567 [TBL] [Abstract][Full Text] [Related]
6. Salivary cortisol levels and their correlation with plasma ACTH levels in depressed patients before and after the DST. Galard R; Gallart JM; Catalan R; Schwartz S; Arguello JM; Castellanos JM Am J Psychiatry; 1991 Apr; 148(4):505-8. PubMed ID: 1848739 [TBL] [Abstract][Full Text] [Related]
7. BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine. Ninan PT; Shelton RC; Bao W; Guico-Pabia CJ Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():86-91. PubMed ID: 24096053 [TBL] [Abstract][Full Text] [Related]
8. Effects of eicosapentaenoic acid and fluoxetine on plasma cortisol, serum interleukin-1beta and interleukin-6 concentrations in patients with major depressive disorder. Jazayeri S; Keshavarz SA; Tehrani-Doost M; Djalali M; Hosseini M; Amini H; Chamari M; Djazayery A Psychiatry Res; 2010 Jun; 178(1):112-5. PubMed ID: 20466437 [TBL] [Abstract][Full Text] [Related]
9. [Correlations among mood disorder, serum interleukin-2 and interleukin-6 in patients with burning mouth syndrome]. Xia J; Lin M; Jin Z Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Oct; 21(5):377-8. PubMed ID: 14650995 [TBL] [Abstract][Full Text] [Related]
10. The dexamethasone suppression test, the Hamilton Depression Rating Scale and the DSM-III depression categories. Maes M; De Ruyter M; Hobin P; Suy E J Affect Disord; 1986; 10(3):207-14. PubMed ID: 2943774 [TBL] [Abstract][Full Text] [Related]
12. Low levels of transthyretin in the CSF of depressed patients. Sullivan GM; Hatterer JA; Herbert J; Chen X; Roose SP; Attia E; Mann JJ; Marangell LB; Goetz RR; Gorman JM Am J Psychiatry; 1999 May; 156(5):710-5. PubMed ID: 10327903 [TBL] [Abstract][Full Text] [Related]
13. Plasma L-tryptophan/neutral amino acid ratio and dexamethasone suppression in depression. Joseph MS; Brewerton TD; Reus VI; Stebbins GT Psychiatry Res; 1984 Mar; 11(3):185-92. PubMed ID: 6587412 [TBL] [Abstract][Full Text] [Related]
14. The dexamethasone suppression test and sleep electroencephalogram in nonbipolar major depressed inpatients: a multivariate analysis. Hubain PP; Staner L; Dramaix M; Kerkhofs M; Papadimitriou G; Mendlewicz J; Linkowski P Biol Psychiatry; 1998 Feb; 43(3):220-9. PubMed ID: 9494704 [TBL] [Abstract][Full Text] [Related]
15. The cortisol suppression index and the dexamethasone suppression test in major depression. Maes M; De Ruyter M; Suy E Acta Psychiatr Belg; 1987; 87():633-9. PubMed ID: 3452982 [TBL] [Abstract][Full Text] [Related]
16. Plasma levels of interleukin-6, interleukin-10, and interleukin-1 receptor antagonist in depression: comparison between the acute state and after remission. Kubera M; Kenis G; Bosmans E; Zieba A; Dudek D; Nowak G; Maes M Pol J Pharmacol; 2000; 52(3):237-41. PubMed ID: 11055582 [TBL] [Abstract][Full Text] [Related]
17. Biomarkers of depression in cancer patients. Jehn CF; Kuehnhardt D; Bartholomae A; Pfeiffer S; Krebs M; Regierer AC; Schmid P; Possinger K; Flath BC Cancer; 2006 Dec; 107(11):2723-9. PubMed ID: 17036362 [TBL] [Abstract][Full Text] [Related]
18. Cortisol suppression index: a new approach to interpreting the DST in depression. Bernstein JP; Chung SY; Avila KS J Clin Psychiatry; 1982 Dec; 43(12):476-8. PubMed ID: 7161249 [TBL] [Abstract][Full Text] [Related]
19. The serum interleukin-18 is a potential marker for development of post-stroke depression. Yang L; Zhang Z; Sun D; Xu Z; Zhang X; Li L Neurol Res; 2010 May; 32(4):340-6. PubMed ID: 20482998 [TBL] [Abstract][Full Text] [Related]
20. Elevated plasma concentrations of alpha 1-acid glycoprotein, a putative endogenous inhibitor of the tritiated imipramine binding site, in depressed patients. Nemeroff CB; Krishnan KR; Blazer DG; Knight DL; Benjamin D; Meyerson LR Arch Gen Psychiatry; 1990 Apr; 47(4):337-40. PubMed ID: 2157380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]